JMDC Inc. logo

JMDC Inc.

4483.T

JPXHealthcareMedical - Healthcare Information Services

Latest quote

¥3,390

+¥25.00 · +0.74%

Aug 24, 3:30 PM JST

4483.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

JMDC Inc. is a Japanese corporation primarily focused on delivering analytical and statistical services for the medical sector. Its operations are structured across three principal divisions: Healthcare-Big Data, Telemedicine, and Dispensing Pharmacy Support. Within the Healthcare-Big Data segment, the company provides extensive big data solutions tailored for both the medical and life insurance industries. It also offers crucial support services to health insurance associations and local government health programs, develops a robust health data platform, and aids medical institutions. The Telemedicine division facilitates remote medical imaging interpretation through specialized matching services and ASP systems. Concurrently, its Dispensing Pharmacy Support segment develops and markets bespoke business management software specifically designed for dispensing pharmacies. JMDC serves a broad spectrum of clients, including health insurance providers, pharmaceutical manufacturers, life and general insurance companies, and research organizations. The company, established in 2002, maintains its corporate headquarters in Tokyo, Japan.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
Headquarters
JP
CEO
Ryo Noguchi
Listed since
Dec 16, 2019
Employees
2,444

Market position

Volume
143.7K
0.31× average
Average volume
467.52K
Average daily volume
Market cap
221.85B JPY
Beta
0.8
Market reference 1

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
235.01B JPY
EV / EBITDA
17.02×
Earnings yield
3.19%
Free cash flow yield
3.78%

Profitability & efficiency

Return on equity
8.08%
Return on assets
4.27%
Return on invested capital
4.85%

Financial health

Current ratio
2.27×

Earnings

EPS beat rate
55%
6 beats, 5 misses, 0 met estimates
Average EPS surprise
+4.13%
11 comparable reports
Latest EPS result
17.28
Estimate 9.08 · Beat by 90.31%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates55.6839.6923.717.72Q1 '25MissQ2 '25BeatQ3 '25BeatQ4 '25MissQ1 '26BeatQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 5, 2025: actual 25.6, estimate 35.24, surprise -27.36%, Miss. Q2 2025, reported May 7, 2025: actual 52.23, estimate 35.63, surprise +46.59%, Beat. Q3 2025, reported Aug 6, 2025: actual 14.79, estimate 12.61, surprise +17.29%, Beat. Q4 2025, reported Nov 6, 2025: actual 21.56, estimate 24.88, surprise -13.34%, Miss. Q1 2026, reported Feb 5, 2026: actual 37.23, estimate 35.91, surprise +3.68%, Beat. Q2 2026, reported May 8, 2026: actual 29.86, estimate 35.91, surprise -16.85%, Miss. Q3 2026, reported Aug 5, 2026: actual 17.28, estimate 9.08, surprise +90.31%, Beat. Q4 2026, reported Oct 30, 2026: actual —, estimate 26.38, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates15.36B13.29B11.22B9.15BQ1 '25MissQ2 '25MissQ3 '25BeatQ4 '25MissQ1 '26BeatQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 5, 2025: actual 11.41B JPY, estimate 11.84B JPY, surprise -3.68%, Miss. Q2 2025, reported May 7, 2025: actual 11.12B JPY, estimate 13.01B JPY, surprise -14.53%, Miss. Q3 2025, reported Aug 6, 2025: actual 10.73B JPY, estimate 9.74B JPY, surprise +10.12%, Beat. Q4 2025, reported Nov 6, 2025: actual 12.36B JPY, estimate 12.38B JPY, surprise -0.21%, Miss. Q1 2026, reported Feb 5, 2026: actual 13.41B JPY, estimate 13.31B JPY, surprise +0.72%, Beat. Q2 2026, reported May 8, 2026: actual 13.97B JPY, estimate 14.27B JPY, surprise -2.07%, Miss. Q3 2026, reported Aug 5, 2026: actual 12.61B JPY, estimate 12.15B JPY, surprise +3.76%, Beat. Q4 2026, reported Oct 30, 2026: actual —, estimate 14.77B JPY, surprise —, Comparison unavailable.

Corporate actions

Corporate action history

Stock split

Effective Sep 29, 2020

2:1

4483.T peers

Continue in GoAI

Research 4483.T

research.disclaimer